|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/36 | (2006.01) |
| A61K 31/198 | (2006.01) | ||
| A61P 41/00 | (2006.01) | ||
| A61P 7/04 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 47/26 | (2006.01) |
| (11) | Number of the document | 3558381 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17837979.8 |
| Date of filing the European patent application | 2017-12-22 | |
| (97) | Date of publication of the European application | 2019-10-30 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-07 |
| (46) | Date of publication of the claims translation | 2021-08-10 |
| (86) | Number | PCT/FR2017/053839 |
| Date | 2017-12-22 |
| (87) | Number | WO 2018/115800 |
| Date | 2018-06-28 |
| (30) | Number | Date | Country code |
| 1663181 | 2016-12-22 | FR |
| (72) |
DEBRAIZE, Clémence, FR
|
| (73) |
Laboratoire Français du Fractionnement et des Biotechnologies,
Tour W - 102 Terrasse Boieldieu 19ème Étage, 92800 Puteaux,
FR
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Skysta žmogaus fibrinogeno kompozicija |
| LIQUID HUMAN FIBRINOGEN COMPOSITION |
| Payment date | Validity (years) | Amount | |
| 2025-12-02 | 9 | 208.00 EUR |
| 2026-12-22 |